Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASLGlobe Newswire • 23 days ago
Providence, RI, March 28, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...
Share to Feed
In this piece, we will take a look at the 13 hot stocks to invest in according to Wall Street analysts. If you want to skip our overview of the stock market and the latest news, then you can skip...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
PALM BEACH, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this...
Providence, RI, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company which endeavors to accelerate the development of compelling discoveries from top...
Titoli in rialzo
Il titolo NeuBase Therapeutics (NASDAQ:NBSE) ha osservato un incremento del 30,52% a 0,98 dollari durante la sessione after-market di venerd .
Le azioni di Ocean Biomedical...
Acciones al alza
NeuBase Therapeutics (NASDAQ:NBSE) avanzaron un 31,85% para establecerse en los 0,99 d lares durante la sesi n del after-market del viernes.
Ocean Biomedical (NASDAQ:OCEA) subieron...
Acciones al alza
Ocean Biomedical (NASDAQ:OCEA) se anotaron un alza del 66,89% para establecerse en los 0,92 d lares durante la sesi n del regular del viernes.
Maravai LifeSciences (NASDAQ:MRVI...